(Reuters) – Pfizer Inc (N:) on Thursday warned that the continued spread of the coronavirus globally could have an adverse impact on its financial results.
The drugmaker said the outbreak could have an impact on its business, including its manufacturing, supply chain and clinical trial operations. (https://
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.